A Systematic Review and Meta-Analysis of the Incidence and Risk Factors for Major Adverse Cardiovascular Events in Patients with Unrepaired Abdominal Aortic Aneurysms.
Chinmay SharmaTejas P SinghShivshankar ThanigaimaniDomenico NastasiJonathan GolledgePublished in: Biomedicines (2023)
Major adverse cardiovascular events (MACE), including myocardial infarction (MI), stroke and cardiovascular death, cause substantial morbidity and mortality. This review assessed the incidence rate of MACE and the association with modifiable risk factors (diabetes, hypertension) and medication use (aspirin, statins) in patients with unrepaired abdominal aortic aneurysm (AAA). Electronic databases were searched systematically for observational studies reporting the incidence of MI, stroke or cardiovascular death in patients with unrepaired AAAs. The primary outcome was cardiovascular death reported as an incidence rate (events per 100 person-years (PY)). Fourteen studies, including 69,579 participants with a mean follow-up time of 5.4 years, were included. Meta-analysis revealed the overall incidence of cardiovascular death, MI and stroke of 2.31 per 100 PY (95% CI, 1.63-3.26; I 2 = 98%), 1.65 per 100 PY (95% CI, 1.01-2.69, I 2 = 88%) and 0.89 per 100 PY (95% CI, 0.53-1.48, I 2 = 87.0%), respectively. The mean rates of statin and aspirin prescriptions were 58.1% and 53.5%, respectively. In conclusion, there is a substantial incidence of MACE in patients with unrepaired AAA, but the prescription of preventative medication is suboptimal. Greater emphasis should be placed on secondary prevention in this population.
Keyphrases
- cardiovascular events
- risk factors
- cardiovascular disease
- coronary artery disease
- atrial fibrillation
- systematic review
- low dose
- abdominal aortic aneurysm
- adverse drug
- healthcare
- abdominal aortic
- antiplatelet therapy
- single cell
- case control
- adipose tissue
- randomized controlled trial
- acute coronary syndrome
- meta analyses
- big data
- weight loss